| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |